Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-029660)

Filing Details

Accession Number:: 0001209191-19-029660
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-05-14 16:31:09
Reporting Period:: 2019-05-13

Accepted Time:: 2019-05-14 16:31:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1408443	Milestone Pharmaceuticals Inc.	MIST	()	G7

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1388325	A/S Holdings Novo	Tuborg Havnevej 19 Hellerup G7 2900		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2019-05-13	1,377,048	$0.00	1,377,048	No	4	M	Direct
Common Shares	Acquisiton	2019-05-13	964,089	$0.00	2,341,137	No	4	M	Direct
Common Shares	Acquisiton	2019-05-13	333,333	$15.00	2,674,470	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	CLASS C PREFERRED SHARES	Disposition	2019-05-13	1,377,048	$0.00	1,377,048	$0.00
Common Shares	CLASS D PREFERRED SHARES	Disposition	2019-05-13	964,089	$0.00	964,089	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct
0			No	4	M	Direct

Footnotes

Each Class C Preferred share and Class D Preferred share automatically converted into one Common share upon the completion of the initial public offering.